Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03479606 · ClinicalTrials.gov registry record · NA

Online Emotion Regulation Group Intervention

A NA study of Traumatic Brain Injury and Executive Dysfunction, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
137
Enrollment target
1
Study location

NCT03479606: Completed NA study of Traumatic Brain Injury and Executive Dysfunction, sponsored by Icahn School of Medicine at Mount Sinai.

NCT03479606 is a NA study of Traumatic Brain Injury and Executive Dysfunction that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 137 participants, below the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03479606, a NA study of Traumatic Brain Injury and Executive Dysfunction, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
137 participants
Enrollment target
1
Study location

Study Summary

This study will examine the efficacy of an emotion regulation intervention delivered online to individuals with traumatic brain injury (TBI) with deficits in emotion regulation. 104 subjects will be enrolled and will receive 24, 60-minute emotion regulation skills-training sessions twice a week for 12 weeks, delivered online in a group video-conference with 3-5 other participants. Participants will be asked to complete online surveys, lasting approximately 40-50 minutes, every four weeks during the intervention and the 12-week follow-up phase. Attendance and compliance will be tracked, and outcomes will be monitored using online data collection methods.

Primary Outcome

36-item self-report questionnaire that focuses on emotional awareness, acceptance, ability to control impulsivity, and flexible use of strategies.

Conditions Studied

Traumatic Brain Injury Executive Dysfunction Emotion Dysregulation Emotion Dysfunction

Interventions

  • BEHAVIORAL Online Emotion Regulation Skills-training

Study Locations (1)

New York

  • The Brain Injury Research Center at Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 137 participants
Start Date 2018-04-05
Est. Completion 2022-09-30
Phase NA
Icahn School of Medicine at Mount Sinai

708 total trials

What the finished NCT03479606 record still lists

NCT03479606 is an interventional study that assigns participants to a tested intervention. The registered 137 participants enrollment target is mid-sized for trials with a published cap, below the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (50% lower).

The record links to 4 conditions, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Online Emotion Regulation Skills-training is the first listed.

NCT03479606 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT03479606 about?

NCT03479606 is a clinical study titled "Online Emotion Regulation Group Intervention". This study will examine the efficacy of an emotion regulation intervention delivered online to individuals with traumatic brain injury (TBI) with deficits in emotion regulation. 104 subjects will be enrolled and will receive 24, 60-minute emotion regulation skills-training sessions twice a week for ...

What is the current status of trial NCT03479606?

This trial is currently completed. It is a NA study. The enrollment target is 137 participants. The study started on 2018-04-05. Estimated completion is 2022-09-30.

What conditions does trial NCT03479606 study?

This clinical trial studies the following conditions: Traumatic Brain Injury, Executive Dysfunction, Emotion Dysregulation, Emotion Dysfunction.

What interventions are being tested in trial NCT03479606?

The interventions under investigation include: Online Emotion Regulation Skills-training (BEHAVIORAL).

Who is sponsoring clinical trial NCT03479606?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03479606 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03479606's enrollment target sits among peer trials

137 50th of 171 higher than 122 of 171 other Traumatic Brain Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05091424 · 137 participants · Phase 1

    A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

  • NCT05655182 · 137 participants · Phase 1

    A Study of BLB-201 RSV Vaccine in Infants and Children

  • NCT06571669 · 137 participants · NA

    BOOM-IBD2 Pivotal Clinical Trial

  • NCT06644768 · 137 participants · Phase 1

    A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT03479606, the US trial registry maintained by the National Library of Medicine. NCT03479606 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.